Clinical characteristics of patients diagnosed of chronic heart failure attended in Primary Care

Journal article


Research Areas

Publication Details

Subtitle: The CARDIOPRES study
Author list: Roca GCR, Alonso VB, Costa JA, Caro JLL, Moreno FJA, Cervantes CE, Arnal SL, Garrote JAD, Eizagaechevarria NM, Gilarranz AM
Publisher: Elsevier: 12 months
Publication year: 2007
Volume number: 207
Issue number: 7
Start page: 337
End page: 340
Number of pages: 4
ISSN: 0014-2565
Languages: English-Great Britain (EN-GB)


Introduction. Scarce information is available on the clinical characteristics and risk factors of patients with chronic heart failure (CHF) attended in Primary Care (PC) setting. The aim of this study was to analyze the clinical characteristics of this population in PC.Patients and methods. Multicenter, cross-sectional study in patients with CHF, consecutively recruited by 232 physicians in PC. The collected data included sociodemographic, etiologic, clinical and therapeutic variables.Results. Eight hundred forty seven (847) patients were included (age 73.0 +/- 9.6 years; 50.5% men). Of these, 84.3% had arterial hypertension (AHT), 59.2% hypercholesterolemia and 34.9% diabetes mellitus. The most frequent associated clinical disorders were emic heart disease (40.1%) and peripheral artery disease (28.6%). In 69.6% of the patients the physicians knew the type of dysfunction (32.4% systolic, 37.2% diastolic). The main etiologies of CHF were the hypertensive cardiornyopathy (75.0%) and ischemic heart disease (40.1%); the most frequent trigger factor was atrial fibrillation (43.9%). Loop diuretics (72.3%) and angiotensin-converting enzyme inhibitors (60.9%) were the treatments used most and 6.7% of the patients were receiving treatment with beta blockers.Conclusions. AHT appears to be primary cause of CHF in PC. Diastolic dysfunction is more frequent than the systolic one, and the PC physicians do not know the cause of the ventricular dysfunction in one third of the cases. Loop diuretics and angiotensin-converting enzyme inhibitors were the most frequently used in these patients; the use of beta blockers in CHF is very scarce in PC.


No matching items found.


No matching items found.

Last updated on 2019-23-08 at 11:15